Frankfurt
08.07.25 | 08:01
3,080 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,120 | 3,260 | 17:21 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.06. | ACACIA RESEARCH CORP - 8-K, Current Report | 3 | SEC Filings | ||
| 24.06. | Acacia Research announces appointment of Michael Zambito as CFO | 1 | Seeking Alpha | ||
| 24.06. | Acacia Research appoints Michael Zambito as CFO | 1 | Seeking Alpha | ||
| 24.06. | Acacia Research appoints Ernst & Young veteran as new CFO | 1 | Investing.com | ||
| ACACIA RESEARCH Aktie jetzt für 0€ handeln | |||||
| 11.06. | ACACIA RESEARCH CORP - 8-K, Current Report | - | SEC Filings | ||
| 21.05. | ACACIA RESEARCH CORP - 8-K, Current Report | 1 | SEC Filings | ||
| 09.05. | ACACIA RESEARCH CORP - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.05. | Acacia Research Non-GAAP EPS of $0.34 beats by $0.39, revenue of $124.42M | 5 | Seeking Alpha | ||
| 08.05. | ACACIA RESEARCH CORP - 8-K, Current Report | - | SEC Filings | ||
| 07.05. | Acacia Research Q1 2025 Earnings Preview | 1 | Seeking Alpha | ||
| 17.03. | ACACIA RESEARCH CORP - 10-K, Annual Report | 1 | SEC Filings | ||
| 13.03. | Acacia Research Corporation Q4 Earnings Summary | 2 | RTTNews | ||
| 13.03. | Acacia Research Non-GAAP EPS of -$0.07, revenue of $48.84M | 2 | Seeking Alpha | ||
| 13.03. | ACACIA RESEARCH CORP - 8-K, Current Report | 1 | SEC Filings | ||
| 12.03. | Acacia Research Q4 2024 Earnings Preview | 4 | Seeking Alpha | ||
| 12.11.24 | Acacia Research Reports Third Quarter 2024 Financial Results | 1.457 | Business Wire | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today... ► Artikel lesen | |
| 21.10.24 | Acacia Research Corporation Acquires Deflecto | 828 | Business Wire | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, announced... ► Artikel lesen | |
| 08.08.24 | Acacia Research Reports Second Quarter 2024 Financial Results | 755 | Business Wire | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company") today reported financial results for the three and six months ended June 30, 2024. The Company... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 28,150 | -1,75 % | EQS-News: Formycon AG: Bio Usawa wird Vermarktungspartner von FYB201/ BioUcenta (Ranibizumab) in der Region Subsahara-Afrika | EQS-News: Formycon AG
/ Schlagwort(e): Kooperation/Markteinführung
Bio Usawa wird Vermarktungspartner von FYB201/ BioUcenta (Ranibizumab) in der Region Subsahara-Afrika
01.07.2025... ► Artikel lesen | |
| GAUZY | 6,990 | -1,27 % | Gauzy Ltd. - 6-K, Report of foreign issuer | ||
| GOMSPACE | 1,862 | +8,00 % | GOMSPACE GROUP AB: GomSpace secures EUR 18 million (SEK 200 million) in refinanced credit facility | ||
| ONTO INNOVATION | 85,50 | +1,18 % | Onto Innovation stock unchanged as Stifel reiterates Hold rating | ||
| SOLESENCE | 3,650 | -0,82 % | Solésence, Inc.: Solésence Announces Uplisting to Nasdaq | Trading set to begin Tuesday, April 8 under new ticker "SLSN" ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions... ► Artikel lesen | |
| NVE | 65,00 | +1,56 % | Dividendenbekanntmachungen (19.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AFFILIATED MANAGERS GROUP INC US0082521081 0,01 USD 0,0089 EUR AIR LIQUIDE SA FR0000120073 - 3,3 EUR ALA SPA IT0005446700 - 0,75... ► Artikel lesen | |
| NANOVIRICIDES | 1,150 | -3,36 % | NanoViricides: There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug Candidate | SHELTON, CT / ACCESS Newswire / July 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC ) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum... ► Artikel lesen | |
| NANOFORM FINLAND | 1,108 | +3,36 % | Nanoform Finland Oyj: Nanoform starts Pivotal Human Bioequivalence Studies of Nanoenzalutamide | Nanoform Finland Plc | Press Release | June 12, 2025 at 08:10:00 EEST
HELSINKI, FINLAND, June 12, 2025 - Nanoform Finland Plc, the medicine performance-enhancing company, today announced that it had... ► Artikel lesen | |
| KOPIN | 1,291 | -2,71 % | Kopin Corporation: Kopin to Showcase Portfolio of Spatial Light Modulators and Microdisplays at Laser World of Photonics 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,045 | -9,56 % | Fendx Technologies Inc: Fendx renews IR agreement with Outside The Box | ||
| ZENTEK | 0,930 | -2,11 % | Zentek und Teufelberger geben Umreifungsbändern ein zweites Leben: Zentek und Teufelberger überführen ... | ||
| VEECO INSTRUMENTS | 17,400 | -3,33 % | Veeco Instruments Inc.: Veeco Updates Fourth Quarter and Full Year 2024 Guidance | PLAINVIEW, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today has updated its financial guidance for the fourth quarter and full year 2024. We expect revenue for... ► Artikel lesen | |
| OBDUCAT | 0,040 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,452 | +5,61 % | ADVANCE ZINCTEK LIMITED: Update on $2.7 Million Profit Turnaround | ||
| LEHNER INVESTMENTS | 0,040 | 0,00 % | EQS-News: LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Jahresergebnis
LEHNER INVESTMENTS AG: Jahresabschluss 2024 mit positivem Ergebnis
30.06.2025 / 16:18 CET/CEST
Für den... ► Artikel lesen |
ACACIA RESEARCH CORPORATION gehört der Branche Nanotechnologie an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 3,080 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACACIA RESEARCH CORPORATION finden Sie auf Wallstreet Online.